Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Using the best available evidence, ASCO expert panels identify and develop practice recommendations for specific areas of cancer care that would benefit from using practice guidelines. Learn more about ASCO's Guideline Development Process.
In addition, the Practice Guidelines Implementation Network (PGIN) is a working group focused on the dissemination and implementation of ASCO guidelines. PGIN member activities include serving on Guideline Expert Panels; reviewing Guidelines; promoting dissemination of Guidelines and Clinical Tools; and reviewing and pilot testing selected Clinical Tools. PGIN members participate in these activities with the goal of assisting practices to increase the quality of oncology care, including facilitating shared decision-making with people with cancer and their caregivers. Members include oncologists, primarily community-based, oncology nurses, hematology/oncology pharmacists, and oncology practice managers. To learn more about PGIN and to join the Network, please contact firstname.lastname@example.org.
Guidelines containing this symbol indicate an associated QOPI® Measure.
Chemo- and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineSeptember 2, 2014
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused UpdateMay 27, 2014
Assays and Predictive Markers
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline UpdateNovember 1, 2013
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance AssaysAugust 20, 2011
Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline EndorsementNovember 12, 2013
ASCO Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients with Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody TherapyJanuary 12, 2009
Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline EndorsementNovember 4, 2014
Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC): American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice GuidelineSeptember 8, 2014
Head and Neck Cancer
Molecular Testing for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the CAP/IASLC/AMP GuidelineOctober 13, 2014
The role of CT screening for Lung Cancer in clinical practice. The evidence based practice guideline of the American College of Chest Physicians and the American Society for Clinical OncologyMay 20, 2012
Supportive Care and Quality of Life
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineApril 14, 2014
Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline AdaptationApril 14, 2014